257 related articles for article (PubMed ID: 6243720)
1. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
[TBL] [Abstract][Full Text] [Related]
3. The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants.
Wanebo HJ; Fukuda M; Tsuei L; Sarkar N; Ashikari H
Surgery; 1979 Aug; 86(2):275-83. PubMed ID: 462374
[TBL] [Abstract][Full Text] [Related]
4. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
[No Abstract] [Full Text] [Related]
6. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
7. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
8. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
[TBL] [Abstract][Full Text] [Related]
9. Geographic and family studies of immunological responses to antigens of the murine mammary tumor virus in sera of patients with breast cancer.
Day NK; Witkin SS; Sarkar NH; Kinne D; Jussawalla DJ; Levin A; Hsia CC; Good RA
Trans Assoc Am Physicians; 1980; 93():123-9. PubMed ID: 6264656
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cellular immune response to cancer of the breast.
Herberman RB
Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.
Lopez DM; Parks WP; Silverman MA; Distasio JA
J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
Surg Forum; 1978; 29():167-9. PubMed ID: 233830
[No Abstract] [Full Text] [Related]
13. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
[No Abstract] [Full Text] [Related]
14. Responses of serum from breast cancer patients to murine mammary tumor virus: fact or artifact?
Dion AS; Girardi AJ; Williams CC; Pomenti AA; Redfield ES
J Natl Cancer Inst; 1987 Aug; 79(2):207-11. PubMed ID: 3037149
[TBL] [Abstract][Full Text] [Related]
15. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues.
Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP
Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264
[No Abstract] [Full Text] [Related]
16. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
[No Abstract] [Full Text] [Related]
17. Antibodies to MuMTV proteins in the sera of mammary carcinoma patients' healthy daughters.
Litvinov S; Kryukova I; Hint E; Purde M
Arch Geschwulstforsch; 1986; 56(6):407-12. PubMed ID: 3030219
[TBL] [Abstract][Full Text] [Related]
18. [Presence of antibodies specifically reacting with structural proteins of the mammary cancer virus among antibodies found in circulating immune complexes in patients with breast cancer].
Litvinov SV; Malivanova TF; Chuev IuV; Kriukova IN
Biull Eksp Biol Med; 1988 Apr; 105(4):475-7. PubMed ID: 2833956
[TBL] [Abstract][Full Text] [Related]
19. Cellular antitumor immune response in women with risk factors for breast cancer.
Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
[TBL] [Abstract][Full Text] [Related]
20. Early detection of breast cancer by leukocyte adherence inhibition assay.
Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
